News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>CICC: INNOVENT BIO (01801.HK) Innovation Drives Strong Results Growth; 2026 Earnings Forecast Raised
INNOVENT BIO (01801.HK) forecasted a 2025 product revenue of approx. RMB11.9 billion, up about 45% YoY, according to CICC's research report. Of which, 4Q25 product revenue amou...
Reset
Send
The window will close in 5 seconds
<Research>CICC: INNOVENT BIO (01801.HK) Innovation Drives Strong Results Growth; 2026 Earnings Forecast Raised
Close
Recommend
3
Positive
12
Negative
1
 
SHORT SELL
 
STOCK INFO

INNOVENT BIO (01801.HK)  0.000 (0.000%)    Short selling $138.95M; Ratio 17.286%   forecasted a 2025 product revenue of approx. RMB11.9 billion, up about 45% YoY, according to CICC's research report. Of which, 4Q25 product revenue amounted to approx. RMB3.3 billion, up over 60% YoY, in line with CICC's expectations.

Taking into account the impact of the 2026 Takeda collaboration, the broker raised its 2026 net profit attributable to parent company forecast by 274% to RMB6.68 billion, and introduced a 2027 net profit attributable to parent company forecast of RMB4.14 billion. CICC kept rating at Outperform.

Related NewsG Sachs: INNOVENT BIO (01801.HK) Achieves Strong Product Sales Last Yr w/ TP $102.85, Rating Buy
Due to the recent decline in the valuation pivot of innovative drugs, based on the DCF model, the broker also kept its target price unchanged at $118.3, representing an upside room of 48.06% from the current share price.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-02-11 16:25.)

AASTOCKS Financial News
Website: www.aastocks.com
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.